TY - JOUR
T1 - On the uptake of cationic liposomes by cells
T2 - From changes in elasticity to internalization
AU - Botet-Carreras, Adrià
AU - Marimon, Manel Bosch
AU - Millan-Solsona, Ruben
AU - Aubets, Eva
AU - Ciudad, Carlos J.
AU - Noé, Véronique
AU - Montero, M. Teresa
AU - Domènech, Òscar
AU - Borrell, Jordi H.
N1 - Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2023/1
Y1 - 2023/1
N2 - In this study, we assessed the capacity of a previously reported engineered liposomal formulation, which had been tested against model membranes mimicking the lipid composition of the HeLa plasma membrane, to fuse and function as a nanocarrier in cells. We used atomic force microscopy to observe physicochemical changes on the cell surface and confocal microscopy to determine how the liposomes interact with cell membranes and released their load. In addition, we performed viability assays using methotrexate as an active drug to obtain proof of concept of the formulation´s capacity to function as a drug delivery-system. The interaction of engineered liposomes with living cells corroborates the information obtained using model membranes and supports the capacity of the engineered liposomal formulation to serve as a potential nanocarrier.
AB - In this study, we assessed the capacity of a previously reported engineered liposomal formulation, which had been tested against model membranes mimicking the lipid composition of the HeLa plasma membrane, to fuse and function as a nanocarrier in cells. We used atomic force microscopy to observe physicochemical changes on the cell surface and confocal microscopy to determine how the liposomes interact with cell membranes and released their load. In addition, we performed viability assays using methotrexate as an active drug to obtain proof of concept of the formulation´s capacity to function as a drug delivery-system. The interaction of engineered liposomes with living cells corroborates the information obtained using model membranes and supports the capacity of the engineered liposomal formulation to serve as a potential nanocarrier.
KW - Atomic force microscopy
KW - Confocal microscopy
KW - Drug delivery system
KW - Engineered liposomes
KW - Filopodia
KW - Young´s modulus
UR - http://www.scopus.com/inward/record.url?scp=85141257037&partnerID=8YFLogxK
U2 - 10.1016/j.colsurfb.2022.112968
DO - 10.1016/j.colsurfb.2022.112968
M3 - Article
C2 - 36335823
AN - SCOPUS:85141257037
SN - 0927-7765
VL - 221
JO - Colloids and Surfaces B: Biointerfaces
JF - Colloids and Surfaces B: Biointerfaces
M1 - 112968
ER -